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 Introduction 
 In all mammalian species the transition from virgin-
ity to motherhood represents a time when a host of chang-
es occur in order to prepare the female for the challenges 
of maternity. Thus, the onset of maternal behaviours, 
such as maternal care and aggression, lactogenesis and 
milk ejection, represent such essential alterations in be-
haviour and physiology from virgins to the lactating 
mother  [1–3] . These changes together with numerous 
other alterations at physiological, cellular and molecular 
levels act in concert to ensure the healthy survival and 
nurturance of the offspring  [4, 5] . Thus, towards the end 
of pregnancy, and into lactation, a dampened (re)activity 
of the hypothalamo-pituitary-adrenal (HPA) axis ap-
pears to be essential for the healthy development of the 
offspring, as high levels of circulating corticosteroids can 
have severe consequences on fetal development  [6] . This 
has been reported in various mammalian species includ-
ing mice, rats, sheep, non-human primates and cows  [1, 
2, 7–10] . However, most of our basic knowledge regarding 
peripartum adaptations comes from studies on labora-
tory rodents. For example, in rats, there are changes in 
behaviour, with increased anxiety reported in mid-late 
pregnancy  [1, 11] , whereas reduced anxiety is found in 
lactation  [1, 3, 12, 13] . These findings are in agreement 
with human studies, as an increased calmness has been 
reported in lactating women  [14, 15] .
 Key Words 
 Oxytocin   Prolactin   HPA axis   Anxiety   Maternal 
behaviour 
 Abstract 
 The peripartum period, in all mammalian species, is charac-
terised by numerous adaptations at neuroendocrine, molec-
ular and behavioural levels that prepare the female for the 
challenges of motherhood. These changes have been well 
characterised and, while they are necessary to ensure the 
survival and nurturance of the offspring, there is growing 
belief that they are also required for maternal mental health. 
Thus, while increased calmness and attenuated stress re-
sponsivity are common characteristics of the peripartum pe-
riod, it also represents a time of increased susceptibility to 
mood disorders. While a number of risk factors for these dis-
orders are known, their underlying aetiology remains poorly 
understood, due at least in part to a lack of appropriate ani-
mal models. One translatable risk factor is stress exposure 
during the peripartum period. In the following review we 
first describe common peripartum adaptations and the im-
pact postpartum mood disorders have on these. We then 
discuss the known consequences of peripartum stress expo-
sure on such maternal adaptations that have been described 
in basic research.  Copyright © 2011 S. Karger AG, Basel 
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 While such changes are essential to ensure the healthy 
development of the offspring, there is growing evidence 
that they are also required for maternal mental health  [5] . 
Thus, it has been shown that the peripartum period rep-
resents a time with high risk for women to develop mood 
and anxiety disorders, such as postpartum anxiety  [16] , 
postpartum depression (PPD)  [17, 18] or the much rarer 
postpartum psychosis (PPP)  [19, 20] . A number of risk 
factors for the development of these postpartum mood 
and anxiety disorders are known, including smoking  [21] 
and alcohol abuse  [22] . More translational risk factors 
that can be modelled in preclinical research include a his-
tory of anxiety or depression  [23, 24] , the social status of 
the mother  [25, 26] , or stressful events during pregnancy 
 [18] . Although the physiological adaptations that occur 
throughout the peripartum period are well known, the 
mechanisms underlying postpartum mood and anxiety 
disorders remain elusive. However, given the clear asso-
ciation between stress and mood and anxiety disorders 
 [27] , recent research assessing the impact of stress during 
the peripartum period is beginning to shed light on po-
tential mechanisms that may be involved in these disor-
ders. Therefore, in the following review, we will describe 
the known consequences of chronic or repeated stress 
during the peripartum period on common adaptations 
that occur during this sensitive period that will hope-
fully lead to a better understanding of maternal mental 
health.
 Peripartum-Related Adaptations 
 Before describing the consequences of chronic stress 
during the peripartum period, we will first discuss the 
adaptations that occur during this period. These changes, 
and the neural circuitry involved in their onset and main-
tenance, have been extensively discussed elsewhere, and 
we would direct the interested reader to the following re-
views  [1, 2, 4, 5, 8, 19, 28] and to  table 1 , which summaris-
es the findings.
 Neuroendocrine and Molecular Alterations 
 Towards the end of pregnancy, and into lactation, the 
response of the HPA axis to a variety of stressors has been 
shown to be severely attenuated in mothers  [15, 29] ; de-
spite a concurrent hypercortisolism under basal (i.e. nor-
mal non-stressed) conditions compared with the respec-
tive level in nulliparous animals/virgins  [30] . Such a bas-
al elevation in glucocorticoids and attenuated HPA axis 
response to stress has been identified not only in humans, 
but also in numerous other species including rats, mice 
and sheep  [8, 11, 31–36] . Increased expression of the neu-
ropeptide vasopressin (AVP) in parvocellular paraven-
tricular nucleus (PVN) neurons  [37] , accompanied by an 
enhanced sensitivity of the pituitary to AVP  [38] , may 
contribute to the heightened basal activity of the HPA 
axis in lactation. Moreover, animal studies have shown 
that the reduced peak HPA axis activity predominantly 
Table 1.  Examples of neuroendocrine and behavioural alterations observed in pregnancy and lactation as assessed in rodent and hu-
man studies
Common peripartum adaptations Time of occurrence References
animal studies
References
human studies
Neuronal and neuroendocrine adaptations
Chronic basal hypercorticism/hypercortisolism lactation 3, 8, 36, 210, 211 29, 30, 130, 212
Deceased responsiveness of HPA axis to stressors lactation 11, 36, 40, 41, 213, 214 15, 204, 215
Decreased CRH mRNA expression in the PVN lactation 9, 37, 39–41 n.a.
Decreased CRH binding in the adenohypophysis pregnancy and lactation 9, 11, 38 n.a.
Decreased noradrenergic input to PVN neurons end of pregnancy and lactation 7, 44 n.a.
Attenuated pituitary sensitivity to CRH pregnancy and lactation 11, 38 n.a.
Altered size and branching pattern of dendritic trees in the PVN lactation 50 n.a.
Altered synaptic neuronal-glial interaction lactation 51, 52 n.a.
Increased OXT mRNA and OXT-R mRNA expression in the PVN lactation 5, 41, 53, 54, 77, 216 n.a.
Decreased ACTH secretion by systemic OXT after stress lactation 217 n.a.
Behavioural alterations
Increased maternal behaviour lactation 1, 2, 48, 81 2, 218
Increased maternal aggression lactation 1, 76, 82, 89, 219 n.a.
Increased calmness, decreased anxiety and responsiveness to stressors lactation 12, 34, 49, 90 15, 29
A CTH = Adrenocorticotropic hormone; CRH = corticotropin-releasing hormone; HPA = hypothalamo-pituitary-adrenal axis; n.a. = not assessed; 
OXT = oxytocin; OXT-R = oxytocin receptor; PVN = paraventricular nucleus of the hypothalamus.
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results from a markedly reduced corticotrophin-releas-
ing hormone (CRH) mRNA expression in the PVN  [37, 
39–41] , as well as a reduced CRH binding in the adeno-
hypophysis during pregnancy  [11] and lactation  [38] . 
Taken together, these alterations lead to a reduced CRH 
production and CRH release by PVN neurons, which is 
also accompanied by a decreased ACTH secretory re-
sponse to CRH  [38, 42] .
 Further central changes which occur to attenuate the 
HPA axis responsiveness include an altered pattern of the 
excitatory inputs to the hypothalamus  [43] . For example, 
there are excitatory noradrenergic projections from the 
brainstem that project to CRH neurons of the PVN that 
promote CRH release, which in turn increases HPA axis 
activity  [7] . However, during the peripartum period these 
projections exhibit a reduced influence on PVN neurons 
 [7] , which, in addition to a decreased expression of nor-
adrenergic   1A -adrenoceptors, leads to decreased basal 
noradrenergic tone within the PVN  [44] . A further excit-
atory pathway that is altered in the peripartum period is 
that of the opioidergic system, which is actually reversed 
to inhibit HPA axis activity around birth  [30, 43, 45, 46] .
 In parallel with the reduction of these excitatory in-
puts to the hypothalamus, inhibitory pathways, includ-
ing those of oxytocin (OXT) and prolactin (PRL), are 
highly activated. These two neuropeptide systems medi-
ate key roles in reproductive functions, such as the pro-
motion of labour, lactogenesis, milk ejection and mater-
nal behaviour  [19, 28, 47, 48] , but have also been shown to 
modulate the HPA axis response to stress  [34, 49] . The 
oxytocinergic system within the hypothalamus under-
goes fundamental structural and functional reorganisa-
tion in the peripartum period. This is reflected by altered 
size and branching patterns of dendritic trees within the 
PVN and SON  [50] and increased synaptic and neuronal-
glial interaction  [51, 52] . Further, it has been shown that 
OXT mRNA, OXT receptor (OXT-R) expression in the 
PVN  [53, 54] and central OXT release  [34, 55–58] are in-
creased in the peripartum period. It has been shown, in 
males and females, that such an activated OXT system is 
accompanied by a decreased ACTH and corticosterone 
response to acute stressors  [59–61] .
 During the peripartum period there is also an upregu-
lation of the PRL system, as evidenced by heightened cen-
tral PRL tone and receptor expression in various regions 
including the PVN, SON and medial preoptic area (both 
the long- and short-receptor forms) – areas that are all 
important for maternal behaviour  [62–65] . It has been 
shown that this activation is also involved in the stress 
attenuation observed in the peripartum period. In more 
detail, downregulation of PRL receptors (PRL-R) in 
dams, via chronic intracerebroventricular infusion of a 
PRL-R antisense oligonucleotide probe, resulted in a 
greater stress-induced plasma ACTH and OXT levels 
compared with controls  [49, 66] . This finding demon-
strates the causal relationship between the increased ac-
tivity of the PRL system and decreased stress responsive-
ness in the peripartum period. Given the similarity in the 
actions of these neuropeptides, it is perhaps not surpris-
ing to find that there is substantial evidence for an inter-
action between the two. Thus, PRL-Rs have been de-
scribed on OXT (and AVP) magnocellular PVN neurons 
 [63, 64] . Further, it has been demonstrated that PRL can 
stimulate OXT release from isolated neural lobes, but 
only during parallel electrical stimulation  [67] . Addition-
ally, PRL administration to hypothalamo-neurohypoph-
yseal system explants, from rats in mid-lactation, was 
shown to increase OXT release and OXT mRNA expres-
sion, but again only under conditions that stimulated 
OXT release  [68, 69] . Increased OXT mRNA expression 
within the PVN has also been observed in pseudo-preg-
nant rats (e.g. treated with steroids to mimic late pregnant 
levels), an effect that can be blocked by administration of 
bromocriptine, an agent that decreases PRL secretion 
 [70] . Moreover, OXT administration can increase PRL re-
lease from the pituitary of oestrogen-primed ovariec-
tomised rats  [71] . These effects may be mediated via a 
PRL-induced increase in nitric oxide synthase activity, as 
has been shown in pregnant rats and in males  [70, 72] . 
However, it was recently demonstrated that the cells that 
increase in PRL sensitivity, as assessed 5 weeks after 
weaning, were non-oxytocinergic neurons suggesting 
that the upregulation observed in the peripartum period 
may be in CRH or AVP neurons  [73] . Taken together, the 
majority of available evidence suggests that the OXT and 
PRL system act synergistically in the peripartum period, 
to protect the late pregnant and lactating mother from 
over-responding to a stressor, such alterations are likely 
in turn to alter the behavioural repertoire shown during 
this time.
 Behavioural Alterations 
 Obviously, one key behavioural change that occurs in 
the peripartum period is the display of maternal behav-
iour, including maternal aggression. The majority of ani-
mal species are not spontaneously maternal, and require 
repeated exposure to young in order to display maternal 
behaviour, whereas almost all new mothers immediately 
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display such behaviour. Brain factors that have been 
shown to significantly contribute to the onset and main-
tenance of the complex repertoire of maternal behaviours 
include the elevated availability of the neuropeptides 
OXT  [2, 74] , PRL  [49, 75] , as well as AVP  [76–80] and their 
receptors. Moreover, the rapid fall in plasma progesterone 
and testosterone (that occurs between pregnancy days 18 
and 21 in rodents), as well as the decreased activity of the 
CRH system, have been shown to be of importance for the 
onset of maternal behaviour and aggression  [48, 81, 82] . 
These alterations act in concert to result in an increased 
display of aggression towards intruders with a concurrent 
decrease in anxiety  [34, 37, 49, 83] . In detail, treatment 
with an OXT antagonist 10 min prior to elevated plus 
maze testing enhanced the anxiety-related behaviour in 
pregnant and lactating, but not virgin rats, suggesting 
that the anxiolytic action of endogenous OXT is restrict-
ed to the peripartum period, i.e. to when its activity is 
elevated  [34] . Chronic administration of a PRL-R anti-
sense oligonucleotide increased anxiety-related behav-
iour in lactating dams  [49] , while administration of bro-
mocriptine during early pregnancy was shown to lead to 
elevated levels of anxiety in the postpartum period  [83] . 
These two studies suggest that the increase in PRL activ-
ity during the peripartum period, at least in part, medi-
ates the decreased anxiety observed at this time. More-
over, an inverse relationship between decreased anxiety 
and increased aggression during the lactation period has 
been shown in rodents  [84–86] . Thus, increasing CRH 
availability, either by intracerebroventricular infusion of 
CRH, or knocking out CRH binding protein, results in 
lower levels of maternal aggression  [87, 88] . These find-
ings suggest that the peripartum-associated decrease in 
CRH system activity is important for the expression of 
maternal aggression and reduced anxiety. Both increased 
maternal offensive behaviour, as well as a reduction in 
anxiety, are important to ensure the protection of the off-
spring  [89, 90] . However, it is also likely that this peripar-
tum-associated anxiolysis, as well as increased calmness 
observed particularly in breast-feeding mothers  [12, 15, 
29] , are important for maternal mental health.
 Postpartum Mood and Anxiety Disorders 
 Although, in general, the peripartum period is a time 
of reduced stress responsivity and increased calmness, as 
described above, for a large percentage of mothers it can 
represent a time of increased susceptibility to mood dis-
orders. Indeed, the peripartum period is believed to rep-
resent the time when a woman is at most risk to develop 
a mood disorder, such a depression.
 Postpartum mood and anxiety disorders can be di-
vided into four main groups  [91] , which are summarised 
below.
 Postpartum Blues or Baby Blues 
 30–75% of mothers are affected by this short-lasting 
mood disturbance  [92] . It appears between the 3rd and 
5th day postpartum as a normal reaction to the changing 
steroid-hormone levels and disappears in most of the cas-
es within a week without any treatment. Symptoms in-
clude mood lability, frequent crying, sleep disturbance, 
irritability and anxiety  [92–94] .
 Postpartum Depression (PPD) 
 This major depressive disorder, which starts within 
the first 4 weeks after birth, occurs in 10–22% of mothers 
and can be a result of long-lasting PPB  [95, 96] . The symp-
tomatology is indistinguishable from depressive episodes 
occurring at other times during a woman’s life  [97] and 
range from depressive mood, loss of general interest – but 
particularly in the baby, sleep and eating disturbances, 
physical agitation, cognitive impairments and high anxi-
ety, to thoughts and attempts of suicide. Studies in wom-
en with major PPD, using the Postpartum Depression 
Screening Scale (PDSS) revealed emotional lability, men-
tal confusion and anxiety/insecurity as core symptoms of 
PPD  [98, 99] . Additionally, it is known from human stud-
ies that mothers with baby blues or PPD find infant stim-
uli, including crying, rather aversive  [100] and that post-
partum depressed women show a reduction in the attach-
ment process as well as an impaired, or even lack of 
maternal care  [101, 102] .
 Postpartum Anxiety 
 Often coincident with PPD, postpartum anxiety disor-
der has an incidence of 5–12% and generally occurs in the 
first 6 months after birth  [23, 103] . There is even some 
evidence that the rate of anxiety disorders peripartum is 
higher than the rate for depression  [104] . Symptoms of 
postpartum anxiety often overlap with those of PPD; 
however, physiological symptoms like clammy hands, tin-
gling or numbness in parts of the body seem to be rather 
apparent than cognitive/behavioural symptoms of gener-
al anxiety disorder symptoms like restless, excessive wor-
ries or irritability  [105] . Moreover, women who suffer 
from this postpartum anxiety show diminished feelings 
of efficacy in their parenting role, a reduction in coping 
capability, reduced maternal reactivity and sensitivity. 
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Additionally, a highly protective maternal style, termed 
‘helicopter parenting’, has also been shown  [19, 106] .
 Postpartum Psychosis (PPP) 
 As arguably the most serious postpartum mood disor-
der, PPP appears within the first 2 weeks after delivery 
 [107] and has an incidence of 1–2 per 1,000 mothers  [108, 
109] . Mothers with PPP often have bipolar  [108, 110] and 
manic symptoms (i.e. euphoria, overactivity, irritability, 
violence)  [110, 111] . Others display severe depression with 
delusions or verbal hallucinations  [112] . Some switch 
from mania to depression (or vice versa) within the same 
episode. PPP always requires the sufferers to be hospital-
ised, because of the danger of suicide and infanticide, 
which is a vital difference to PPD.
 Although these four disorders can be theoretically dis-
tinguished, as can be noted from the symptomatology 
described above, there exists substantial comorbidity 
across the disorders. For example, while postpartum 
blues is not a psychiatric disorder, if the symptoms are 
prolonged for longer than 2 weeks, it is possible that PPD 
can be diagnosed in the mother. Moreover, diagnosis of 
postpartum anxiety represents one of the most robust in-
dicators of a mother subsequently developing PPD  [16] . 
Therefore, it is better to think of these postpartum psy-
chiatric disorders as a continuum with overlapping symp-
tomatology in terms of diagnosis and treatment.
 While the underlying aetiology of peripartum-associ-
ated mood and anxiety disorders is largely unknown, 
various risk factors have been identified that increase 
their likelihood. Among those, environmental factors 
such as smoking  [17, 21] , alcohol abuse  [22] or low socio-
economic status  [25, 26, 113] increase the risk of develop-
ing a postpartum mood or anxiety disorder. Further-
more, prior history of a mental illness including depres-
sive episodes or experiencing anxiety during pregnancy 
 [23] elevates the chance of developing a postpartum 
mood and/or anxiety disorder. One hypothesis for the 
underlying aetiology of postpartum mood and anxiety 
disorders is related to the fluctuation in steroid hormones 
and glucocorticoids during the end of pregnancy  [97, 
113–118] . Thus, oestradiol levels increase 50-fold and 
progesterone levels 10-fold throughout pregnancy, but 
drop to early follicular levels within 1 week after delivery 
 [119, 120] . This dramatic drop in steroid hormones may 
represent a risk factor for postpartum mood and anxiety 
disorders. For example, a stress-related increase in oes-
tradiol, progesterone and cortisol levels, as well as elevat-
ed basal progesterone levels have been observed in moth-
ers with PPD  [121] .
 However, in the majority of depressed patients  [122, 
123] , including PPD  [18, 97, 118] , chronic stress has been 
shown to be one of the most prominent single risk factors, 
after a prior history of depression. Moreover, women have 
been shown to exhibit a higher susceptibility to stress-
related illnesses, such as mood and anxiety disorders, 
than men  [124–126] . Despite the correlation between 
chronic stress during pregnancy and the development of 
a depression after birth, studies assessing the effects of 
chronic stress during pregnancy on peripartum adapta-
tions in humans are largely missing. Thus, the following 
section details the impact of postpartum mood disorders 
on the mother and, consequently, impaired mother-in-
fant relationship, regardless of the underlying cause.
 Given the profound physiological alterations that oc-
cur during the peripartum period at the level of the HPA 
axis, it has also been speculated that circumstances which 
prevent these adaptations may underlie, at least in some 
instances, postpartum mood and anxiety disorders  [5, 
12] . This is based on the large body of evidence showing 
that in a subpopulation of depressed women, high levels 
of cortisol exist, together with an inhibited negative feed-
back, as well as an abnormal diurnal secretion pattern of 
cortisol  [123, 127, 128] . There is also recent evidence 
showing that abnormal levels of cortisol, whether too 
high or too low, resulted in a greater risk of major depres-
sion  [129] . Interestingly, a recent study demonstrated that 
women with PPD exhibited a decreased cortisol-awaken-
ing response compared with healthy mothers  [130] . This 
finding could imply that PPD is associated with an abol-
ished physiological hypercortisolism and rather resem-
bles a hypocortisol disorder, such as post-traumatic stress 
disorder or chronic fatigue syndrome  [130] . In agree-
ment, postpartum fatigue has been recently demonstrat-
ed to be correlated with the amount of perceived stress 
during the last 2 weeks of pregnancy and, moreover, rep-
resents a particularly prevalent symptom of PPD  [131, 
132] . Furthermore, a more pronounced attenuation of the 
ACTH response to a CRH bolus was found in women 
with postpartum blues compared with euthymic women 
 [133] . These findings suggest that prevention of the nor-
mal peripartum adaptations at the level of the HPA axis 
can be detrimental for the mother’s mental health.
 A strong relationship between PRL and maternal 
mood has also been reported. For example, high circulat-
ing PRL levels in breast-feeding women have been associ-
ated with hypoanxiety  [134] , while lower levels have been 
linked with an increased incidence of depression  [114] . 
Breast-feeding has been demonstrated to increase plasma 
PRL and OXT levels in women  [59, 135] , which is likely to 
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be accompanied by increased central release of these neu-
ropeptides  [56, 57, 136] . Interestingly, women who breast-
fed their babies prior to acute stress test were shown to 
have an attenuated stress-induced rise in cortisol com-
pared with non-breast-feeding lactating mothers  [15] , 
suggesting an involvement of brain PRL and OXT in the 
peripartum-related calmness. Similarly, women who dis-
play a high-interaction level with their children also ex-
hibit a dramatic rise in plasma OXT  [137] . Such an in-
crease appears to be beneficial for the mother, as first-
time mothers who display low infant-attachment ratings 
displayed a reduced plasma OXT response when interact-
ing with their children, as well as reduced activation of 
the reward circuitry  [138] . Furthermore, plasma OXT lev-
els are decreased in cocaine-addicted mothers, who are 
more likely to have psychiatric disorders and less attach-
ment to their infants  [139] . The importance of OXT for a 
mother’s mental health was recently demonstrated in a 
study showing that low levels of plasma OXT during mid-
pregnancy significantly predicted the development of 
PPD symptoms within 2 weeks of parturition  [140] . Fi-
nally, while not in the peripartum period, women who 
had experienced childhood trauma were shown to have 
lower cerebrospinal fluid levels of OXT than controls; the 
levels of which negatively correlated their current anxiety 
ratings  [141] . Therefore, taken together, these findings 
implicate a reduced activity level of the brain OXT and 
PRL systems in postpartum mood and anxiety disorders 
due, in part, to the subsequent effect on HPA axis adapta-
tions, behaviour and mother-infant relationship.
 Postpartum mood and anxiety disorders are also as-
sociated with dramatic alterations in maternal behaviour 
towards her newborn. Thus, while PPD is associated with 
reduced interaction between the mother and infant  [142–
144] , postpartum anxiety can rather lead to the opposite. 
It has been shown in a number of species that highly anx-
ious mothers tend to ruminate over the health and well-
being of their babies (helicopter parenting)  [19, 77, 145] . 
More seriously, in the case of PPP, mothers may actually 
attempt infanticide or suicide  [ for review, see  146] . In sup-
port, rodent studies have shown a close link between the 
dam’s level of anxiety and the display of maternal care 
and maternal defence behaviour with difference in the 
brain AVP and OXT systems underlying this correlation 
(see Bosch  [28] for a comprehensive review).
 In general, alterations in mother-infant interactions 
have detrimental long-lasting effects on the children who 
grow up with a much higher risk of developing a mood 
disorder, substance abuse and cognitive impairments 
 [147–149] . It is likely that these alterations in maternal 
behaviour are related, at least in part, to the neuroendo-
crine findings detailed above.
 Given the complexity of physiological peripartum ad-
aptations, which cannot be readily studied in humans, 
factors that determine the aetiology of postpartum mood 
and anxiety disorders need to be clearly identified in rel-
evant animal models.
 Chronic Stress Paradigms in Male and Female Rats 
 In order to examine the effect of stress on peripartum 
adaptations, appropriate animal models are required. 
Despite the fact that women are twice as likely to develop 
stress-related disorders, most basic studies assessing the 
detrimental effects of chronic stress are performed in 
males. This is due, in part, to the complexity of studying 
chronic stress in females, given the differences in a num-
ber of factors that are observed across the oestrus cycle, 
which have to be considered such as OXT-R expression 
 [150] and HPA axis activity  [151] . Moreover, chronic 
stress exposure can lead to a lengthening of the oestrus 
cycle  [152] , complicating the choice of appropriate con-
trols. In light of this, it is important to note that forms of 
stress that are effective in males may not be in females 
and vice versa. While physiological stressors, such as re-
straint or swim stress, work in both males and females, 
there has been a recent shift towards employing chronic 
psychosocial stressors, which are believed to be more rel-
evant to the human situation than non-social stress par-
adigms  [27, 153] . However, males and females respond 
differently to social stress paradigms. Hence, it arises 
that defeat by aggressive male residents induces classical 
stress-related changes like decreased body weight gain, 
increased adrenal size and increase in basal corticoste-
rone levels in males  [154] , but not in females  [155] . In 
contrast, clear-cut signs of chronic stress (i.e. thymus in-
volution, adrenal hypertrophy) are observed in females 
after exposure to social instability conditions, induced 
by mixed-sex crowding and alternating isolation phases 
 [155–159] . One reason for the variability regarding the 
response to different stressors may underlie the fact that 
it is difficult to obtain strong dominance or high aggres-
sion in virgin females. Here, the naturally-occurring 
high aggression potential found in lactating rat dams has 
been successfully utilised in order to inflict defeat on vir-
gin (or pregnant) females, resulting in clear signs of acute 
 [160] or chronic  [161] stress exposure in the female in-
truder. Moreover, there have been trials to induce high 
aggressiveness in females by performing medio-basolat-
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eral hypothalamic lesions  [155] . Therefore, it is impor-
tant when wishing to assess the effect of chronic stress 
exposure on peripartum adaptations to consider the 
choice of stressor carefully, and to verify that the para-
digm chosen leads to hallmark signs of stress exposure 
in the dam.
 Consequences of Chronic Stress in Pregnancy 
on Physiology, Neuroendocrine and Neuronal 
Parameters 
 While it is unlikely that a specific rodent model of
a postpartum mood or anxiety disorder is achievable,
assessment of the behavioural, physiological, molecular 
and neuroendocrine alterations caused by stress expo-
sure in the peripartum period in basic research can pro-
vide a better understanding of the aetiology of the disor-
ders. Moreover, there are a number of different symptom 
clusters that can be modelled relatively easily in rodents. 
This has led to an endophenotype-based approach to 
study psychiatric disorders in preclinical laboratories, 
which attempt to assess only one symptom (cluster), or 
marker, of the disease rather than the whole syndrome 
 [27, 162] . This has the benefit of simplifying a complex 
disorder, such as depression or anxiety, into individual 
behaviours, which are more easily measurable in both pa-
tients and laboratory animals. In order to assess the ef-
fects of chronic stress in relation to peripartum-associat-
ed adaptations in rodents, it is necessary to determine 
whether such stressors, described above, are effective in 
this time of attenuated stress responsivity. Therefore, giv-
en the evidence purporting chronic social stress to be a 
risk factor for the development of depression and anxiety 
in vulnerable individuals, recent attempts, as described 
above, have focussed on the development of chronic so-
cial stress paradigms  [27, 162] . Such paradigms are be-
lieved to be more relevant to the human situation than 
non-social stress paradigms (e.g. repeated restraint) and 
thus can better reveal the behavioural, neuroendocrine or 
immunological consequences of chronic stress in the pe-
ripartum period. However, and analogous to male and 
virgin rodents, repeated restraint stress  [163–165] or 
chronic ultra-mild stress  [166] have also been demon-
strated to be effective peripartum stressors due to their 
alteration of physiological parameters such as body 
weight gain, adrenal weight and plasma glucocorticoid 
levels, as well as offspring indices. It needs to be men-
tioned that the majority of these maternal stress para-
digms are currently used to study the role of early life, e.g. 
prenatal stress on offspring behaviour and physiology, 
rather than on the effects on the mother. Thus, it has been 
extensively shown in animal and human studies that pre-
natal, but also postnatal stress leads to the development 
of psychopathologies later in life, including an increased 
risk for anxiety and depression disorders, schizophrenia 
and substance abuse  [ for reviews, see  167–172] . In the 
context of pregnancy stress, monitoring its multiple ef-
fects on the offspring can be used as an effective valida-
tion of the chronic stress paradigm. However, it arises 
that females subjected to chronic stress during the peri-
partum period show characteristic hallmark behavioural, 
physiological, neuroendocrine and molecular indications 
of stress exposure (summarised in  table 2 ). These param-
eters, in addition to alterations in the offspring, are used 
to verify the stress paradigm. In this section, we describe 
the findings from basic research on the systems described 
above that are known to be altered during the peripartum 
period and/or in postpartum mood and anxiety disor-
ders.
 In our laboratory, in order to examine the effects of 
chronic pregnancy stress on maternal adaptation, we de-
signed a stress paradigm that combined restraint stress (2 
 ! 1 h/day) with periods of overcrowding with unknown 
females, also resulting in social instability as a potent 
stressor in females  [155] . The combination of these two 
stressors has been chosen to include a psychosocial stress 
compound in the model ( fig. 1 ). The different stressors 
were alternated daily between pregnancy days 4 and 16.
 HPA Axis 
 One of the most common findings observed in pa-
tients with psychiatric disorders is dysregulation of the 
HPA axis  [4, 5, 173] , including mothers with postpartum 
mood and anxiety disorders. Therefore, a number of 
Table 2.  Paradigms used to study the effects of chronic stress in 
female rats and mice
Stress paradigm References
Social instability/isolation 155–157, 220, 221
Restraint stress (once daily to
3 times daily, for 1 week or longer)
163–165, 224
Chronic ultra-mild stress 166, 222
Long or brief maternal separation 198, 223
Novel environment 165
Strobe-light stress 177
Exogenous corticosterone 197
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studies have assessed the impact of chronic stress expo-
sure on HPA (re)activity in the peripartum period. We 
could reveal in our paradigm that stressed dams, in ad-
dition to showing hallmark indicators of stress exposure 
(decreased weight gain, increased adrenal weight)  [156, 
174–176, 224] , did not exhibit the lactation-associated 
basal hypercorticism  [1, 8, 13] . Interestingly, as described 
above, a recent study in humans showed decreased awak-
ening cortisol levels in women, who had PPD  [130] . 
Therefore, hypocortisolism may represent a biomarker 
for postpartum mood disorders, and more research is 
warranted to investigate this possibility.
 However, the attenuated ACTH or corticosterone re-
sponse to a (novel) acute stressor was not altered by our 
chronic pregnancy stress paradigm. In contrast to these 
findings, subjecting rats to repeated strobe-light stress 
throughout pregnancy and in lactation resulted in an en-
hanced corticosterone response to stress in the afternoon 
compared to the morning in stressed dams in lactation 
 [177] . Therefore, it appears that depending on the stress 
paradigm employed, different effects on peripartum-as-
sociated HPA axis adaptations can be observed. More-
over, studies in primates could show that daily injection 
of hydrocorticosterone, thereby causing a chronic eleva-
tion in cortisol levels, led to impairments in mother-in-
fant interactions  [178] . Thus, chronic peripartum stress 
can affect both the basal hypercorticism, as well as the 
attenuated stress responsivity observed in lactation. To-
gether with the findings from human studies, the animal 
data suggests that an optimal corticosterone/cortisol 
window exists, in which an elevation above nulliparous/
virgin levels is beneficial while the higher levels observed 
after stress exposure negatively affect maternal care  [ see 
also  179 for more details ] . Consequently, it is suggested 
that such stress-induced prevention of these peripartum-
associated neuroendocrine adaptations may underlie 
postpartum mood disorders  [1, 4, 5] .
 OXT System 
 Given the importance of elevated OXT in the peripar-
tum period, in addition to its stress-attenuating proper-
ties, a number of studies have assessed the impact of 
stress on this neuropeptide in dams. In our stress para-
digm, we could reveal that pregnancy stress prevented the 
peripartum-induced rise in OXT mRNA expression in 
the PVN [224]. This is interesting in the context of the low 
levels of OXT found in primates with low measures of 
‘maternal warmth’, based on frequency of nursing and 
grooming of the infant  [47] and humans with low infant 
attachment, as well as the correlation between plasma 
OXT levels and anxiety in women (see above)  [138, 141, 
180] . While a direct correlation between OXT expression 
in the PVN and plasma levels needs to be shown, a study 
by Otsubo et al.  [181] demonstrated that activation of 
OXT neurons in the PVN and SON by administration of 
adrenomedullin-5 caused activation of OXT neurons and 
a subsequent increase in plasma OXT levels. The impor-
tance of the OXT system in attachment, maternal behav-
iour and its concurrent susceptibility to stress could also 
be shown in recent animal studies from the Meaney 
PD0
Verification of 
pregnancy
Start of stress
procedure
Overcrowding stress;
4 unfamiliar females per cage
End of stress
procedure
2 × 1 h restraint stress;
singly housed
PD1 PD2 PD3 PD4 PD5 PD6 PD7 PD8 PD9 PD10 PD11 PD12 PD13 PD14 PD15 PD16 PD17 PD18 PD19 PD20
 Fig. 1. The chronic psychosocial stress paradigm used between 
PD4 and PD16 for our own peripartum studies. Female rats (preg-
nant or virgin) were housed in cages of 4–5 until PD4 when the 
stress procedure started. On even days between PD4 and PD16 (in 
red), rats were weighed, housed individually and subjected to 2  ! 
1 h restraint stress in a Plexiglas tube (12 cm in diameter, with 
ventilation holes). On odd days (in blue), rats were weighed and 
transferred to overcrowded conditions, consisting of 4 PS rats in 
a small cage (40  ! 25  ! 15 cm). From PD17 onwards, animals 
were singly housed. Control pregnant and virgin rats were main-
tained in cages of 5 throughout the experiment until being trans-
ferred to single housing on PD17 and weighed daily to mimic the 
handling conditions of the stressed group. 
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group  [182–185] , as well as our own studies. The Meaney 
group has established a model of naturally occurring 
variations in maternal behaviour, characterised by dams 
showing either a high frequency of licking and grooming 
their pups (high LG dams) or low (low LG dams) levels. 
They could reveal that high LG dams express higher lev-
els of OXT-R in distinct brain regions known for their 
importance in regulating maternal behaviour, like the 
bed nucleus of the stria terminalis, the medial preoptic 
area and the central amygdala. Interestingly, repeated ex-
posure to restraint stress between pregnancy days 15 and 
21 (3  ! 30 min/day) resulted in a decrease in the expres-
sion of OXT-R comparable to those of low LG dams with 
a concurrent decrease in LG behaviour, e.g. a reduction 
in maternal behaviour.
 Moreover, in rat dams selectively bred for high anxi-
ety-related behaviour (HAB), we found an increased ac-
tivity of the OXT system in lactation as reflected by high-
er levels of OXT release within the central amygdala, 
PVN and medial preoptic area during maternal care and 
aggression. These dams show a markedly reduced anxi-
ety level during lactation, which can be partially reversed 
by blockade of central OXT-Rs, again demonstrating the 
correlation between anxiety and OXT activity  [28] . More-
over, anxiety, local OXT release, but not binding, and a 
high level of maternal care and maternal defence behav-
iour were found to be strongly associated  [76, 77, 84] . Fi-
nally, it has been shown that the majority of stimuli that 
increase central OXT release have also been demonstrat-
ed to increase plasma levels, unlike that of the related 
neuropeptide AVP  [186] . Thus, the findings from rodent 
studies, and those from humans (see above), suggest that 
assessing plasma OXT levels in mothers, as an indirect 
marker of central activity, may also represent a marker for 
postpartum mood and/or anxiety disorders as shown in 
the recent study by Skrundz et al.  [140] , which needs to 
be replicated.
 Neurogenesis 
 There has been substantial interest in recent years re-
garding stress-related disorders, such as depression, and 
neurogenesis  [187] . Thus, several factors like acute and 
chronic stress have been shown to decrease hippocampal 
neurogenesis  [188] and it has been speculated that anti-
depressants require neurogenesis to mediate their benefi-
cial effect  [189] . Moreover, there is a link between the pro-
duction of immature neurons in the hippocampus, as 
well as the subventricular zone (SVZ), and the reproduc-
tive status of a female  [190–192] . It has recently been dem-
onstrated that the high level of PRL during early preg-
nancy leads to an increased number of newly generated 
cells in the SVZ, which migrate to the olfactory bulb to 
play a role in the learning of novel odorants  [193, 194] . 
Thus, the impaired maternal behaviour observed follow-
ing bromocriptine administration, which reduces PRL 
secretion, may be due to a subsequent reduction in the 
number of newly integrated neurons in the olfactory 
bulb. Interestingly, it has been demonstrated that hippo-
campal neurogenesis is decreased during the lactation 
period; an effect that is dependent on the presence of pups 
and the high level of corticosterone. Adrenalectomy, or 
removal of the pups straight after birth, was able to re-
store neurogenesis to the level of virgins due to the con-
comitant decrease in plasma glucocorticoid levels  [188, 
195] . Whether neurogenesis is affected in human moth-
ers remains to be determined, but the findings from these 
rodent studies, together with those showing that antide-
pressants increase neurogenesis in humans  [196] , suggest 
that alterations in neurogenesis may play a role in post-
partum mood and anxiety disorders.
 Consequences of Chronic Stress in Pregnancy on 
Behavioural Parameters 
 In humans, as discussed above, postpartum mood and 
anxiety disorders result in a number of behavioural ad-
aptations, such as interactions with the child, increased 
anxiety or decreased stress coping that can be assessed in 
animal studies. Therefore, a number of studies have de-
termined the effect of chronic stress exposure on the be-
haviour of the dam.
 Maternal Care 
 Maestripieri et al.  [165] could demonstrate that daily
2 h restraint stress between pregnancy days 4 and 14 re-
sulted in decreased maternal aggression in the resident- 
intruder test and an increased latency to retrieve the pups 
in a novel environment during the pup-retrieval test. 
Similarly, an ultra-mild stress paradigm (cage tilt; con-
finement in a small cage and paired housing; overnight 
period with difficult access to food; overnight period 
with permanent light; overnight period in soiled cage; re-
versal of light/dark cycle), delivered over 1 h in the morn-
ing, 2 h in the afternoon and during the night from the 
day of mating till parturition, also resulted in an in-
creased latency in the pup retrieval test  [166] . However, 
while pup retrieval latency was increased, basic maternal 
care was not changed as a result of this stress paradigm 
 [166] .
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 In our studies we could show that lactating dams that 
experienced chronic stress during pregnancy exhibited 
an increase in arched-back (kyphotic) nursing from ear-
ly to mid-lactation compared with unstressed control 
dams (see  fig. 2 )  [224] . However, there are studies show-
ing a decrease in kyphotic nursing after repeated re-
straint stress  [163] or under chronically high levels of 
corticosterone  [197] . The effects of acute separation from 
the pups, also a form of stress, have also been shown to 
affect maternal behaviour with both a reduced maternal 
behaviour  [198] and a higher intensity of maternal care 
being observed  [199] . Interestingly, in our laboratory, re-
peated restraint stress during lactation, which is coupled 
with pup separation, led to an increased display in ma-
ternal behaviour. In contrast, separation alone did not 
affect this behaviour  [Hillerer, unpubl. data] . Further-
more, it has been observed that early-life stress exposure 
leads to a reduction in maternal behaviour when the fe-
male offspring have their first litter  [200] . Thus, as has 
been demonstrated in humans, chronic stress exposure 
during the peripartum period can lead to both increased 
and decreased maternal care/attachment. Therefore, 
further study of the mechanisms underlying the changes 
in the behaviour of dams towards their offspring, as ob-
served in these models, can lead to a better understand-
ing for such behavioural alterations in women with post-
partum mood and anxiety disorders.
 Anxiety 
 Interestingly, there appears to be a correlation be-
tween the effects of peripartum stress on maternal be-
haviour and the impact it has on anxiety-related behav-
iour. We could reveal that our chronic pregnancy stress 
paradigm led to an increase in anxiety-related behaviour 
in two established tests – the elevated plus maze and the 
light-dark box  [224] . These results are in accordance 
with studies in rodents, non-human primates and hu-
mans showing that mothers with high levels of anxiety 
express a high maternal motivation and highly protec-
tive maternal styles, known as helicopter parenting in 
humans  [19, 201, 202] . In support, HAB dams show high-
er levels of arched-back nursing, leave the nest compara-
bly less often and retrieve the pups faster during the pup 
retrieval test even under adverse and challenging condi-
tions  [28, 161] . Moreover, HAB dams show more defen-
sive behaviour during the maternal defence test indicat-
ing high levels of maternal aggression as part of the mul-
tiple facets of maternal behaviour  [1, 84] . Although it 
would normally be perceived as beneficial for the off-
spring to receive such attention/nursing during the early 
postnatal stage, our studies have revealed a detrimental 
outcome of this increased nursing. In detail, when HAB 
offspring were subjected to 3 h maternal separation for 
the first 14 days of life, consequently reducing the re-
ceived amount of nursing, they display reduced anxiety 
in adulthood. In contrast, and as shown in outbred rats, 
low anxiety-related behaviour rats subjected to the same 
maternal separation paradigm displayed an increased 
anxiety level in adulthood  [28, 161] . Moreover, a similar 
trend towards reduced anxiety in adulthood was ob-
served when HAB mice, which also receive increased 
levels of arched-back nursing, were cross-fostered to less 
attentive low anxiety-related behaviour dams  [203] . 
While these correlations have been observed in relation 
to arched-back nursing, it has been demonstrated that 
Long-Evans offspring that receive higher levels of licking 
(a more robust variable in this strain) from their mother 
are less anxious in adulthood than those receiving lower 
levels  [182, 184] . A similar link between maternal at-
tachment and anxiety has also been reported in human 
studies  [15, 204] and thus appears to be an evolutionari-
ly conserved peripartum adaptation. Thus, greater un-
derstanding of the underlying mechanisms of peripar-
tum-associated anxiety and the subsequent alterations 
in these neurobiological mechanisms by chronic stress 
exposure, may provide better insight into postpartum 
mood and anxiety disorders.
LD2
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 Fig. 2. Exposure to chronic psychosocial stress (pregnancy day 
4–16) led to increased arched-back nursing (ABN) from LD2 to 
LD7. Behaviour was scored using a time-sampling technique 
whereby the behaviour of the dam was scored every 2 min be-
tween 06: 00 and 12: 00 h. Data represent mean  8 SEM (n = 12–
17).  *  p  ! 0.05 vs. non-stressed group. 
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 Depression 
 While there is a link between increased maternal be-
haviour and anxiety, there appears to be a similar correla-
tion between decreased maternal behaviour and depres-
sion-related behaviour. For example, increased depres-
sion-like behaviour, as assessed by forced swim test, was 
found after repeated restraint stress from early to late lac-
tation  [163, 165] , as well as following acute separation 
stress  [198] with a concomitant decrease in maternal care. 
Additionally, female rats that were treated with oestra-
diol and progesterone to induce a hormone-stimulated 
pregnancy exhibited a depression-like phenotype (as as-
sessed in the forced swim test and sucrose preference test) 
after withdrawal of the gonadal steroids. Treatment with 
an oestrogen receptor-  agonist was able to alleviate the 
depressive symptoms  [205, 206] . Furthermore, it could be 
shown in different non-human primate species that stress 
induced increases in plasma cortisol concentrations and 
that this rise was associated with abnormal maternal be-
haviour, like infant neglect  [207, 208] . In a recent study by 
Saltzman and Abbott  [178] , it could be shown that exog-
enous administration of cortisol to lactating female mar-
mosets impaired maternal motivation and interfered 
with the expression of appropriate maternal behaviour. 
Furthermore, in rhesus macaque females that abused 
their infants, high levels of aggression were observed as 
well as elevated concentrations of CRH in cerebrospinal 
fluid  [209] . The latter finding further supports the find-
ings in rodents showing that reversal of the peripartum-
associated decrease in CRH leads to an attenuation of the 
concomitant increase in aggression. These findings in ro-
dents and non-human primates are similar to the symp-
toms observed in mothers with PPD, e.g. decreased infant 
attachment. Therefore, further studies in such models 
will greatly assist in determining the mechanisms under-
lying postpartum mood disorders and may thus lead to 
better treatment options.
 Conclusions 
 Numerous studies have revealed important neuroen-
docrine, neuronal and behavioural adaptations that oc-
cur during pregnancy and postpartum. While these ad-
aptations are known to be essential for the survival and 
health of the offspring, there is growing belief that they 
are also required for mother’s successful adaptive re-
sponses to her changing situation. Currently, little is 
known about the aetiology of postpartum mood disor-
ders and it is likely that animal models can only mimic 
certain aspects of the complex symptomatology of these 
disorders. However, assessing the consequences of peri-
partum stress exposure, a major risk factor of the disor-
ders, can provide insight into the mechanisms underly-
ing these disorders. These studies have demonstrated that 
chronic pregnancy stress can affect a number of maternal 
adaptations including the basal elevation in glucocorti-
coids and attenuated stress responsivity, as well as the in-
creased OXT system activity. Moreover, stress can alter 
the behavioural repertoire of the mother, with increased 
anxiety and depression-related behaviour observed in 
several studies. Further, stress exerts a bidirectional in-
fluence on fine-tuned maternal care, with both increased 
and decreased behaviour being observed after chronic 
stress exposure. However, it is clear that more studies are 
required to gain a better understanding of the impact of 
stress on the mother. Thus, while the circuitry involved 
in the onset and maintenance of maternal care is well 
characterised, it remains only supposition at present that 
chronic stress exposure leads to alterations within this 
brain network. Thus, to date, the majority of studies have 
focussed on specific behavioural or neuroendocrine pa-
rameters, and in the future, studies are required that as-
sess the impact of chronic stress on this defined circuitry. 
Such studies seem particularly warranted given the seri-
ous consequences of such disorders on both the mother 
and the offspring.
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